Health
High-affinity SARS-CoV-2 RBD drives mutation spread, forms basis of new COVID-19 inhibitor – News-Medical.Net
Now, an intriguing recent study appeared on the bioRxiv * preprint server describes the use of in vitro evolution to elicit affinity maturation of the viral receptor-binding…
The ongoing coronavirus disease 2019 (COVID-19) pandemic continues to spread, with the virus responsible for it, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) undergoing many mutations that have affected its infectivity. Now, an intriguing recent study appeared on the bioRxiv * preprint server describes the use of in vitro evolution to elicit affinity maturation of the viral receptor-binding domain (RBD) of the spike protein to bind the host cell angiotensin-converting enzyme…
-
Business19 hours agoWarning! These ASX 200 shares were just downgraded
-
Business12 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Business17 hours ago2 monthly payers you’ll want to own in 2025 and beyond
-
Noosa News9 hours agoTwo-time Archibald Prize-winning painter William Robinson has died, aged 89